Literature DB >> 22858388

Cardiovascular disease in the developing world: prevalences, patterns, and the potential of early disease detection.

David S Celermajer1, Clara K Chow, Eloi Marijon, Nicholas M Anstey, Kam S Woo.   

Abstract

Over the past decade or more, the prevalence of traditional risk factors for atherosclerotic cardiovascular diseases has been increasing in the major populous countries of the developing world, including China and India, with consequent increases in the rates of coronary and cerebrovascular events. Indeed, by 2020, cardiovascular diseases are predicted to be the major causes of morbidity and mortality in most developing nations around the world. Techniques for the early detection of arterial damage have provided important insights into disease patterns and pathogenesis and especially the effects of progressive urbanization on cardiovascular risk in these populations. Furthermore, certain other diseases affecting the cardiovascular system remain prevalent and important causes of cardiovascular morbidity and mortality in developing countries, including the cardiac effects of rheumatic heart disease and the vascular effects of malaria. Imaging and functional studies of early cardiovascular changes in those disease processes have also recently been published by various groups, allowing consideration of screening and early treatment opportunities. In this report, the authors review the prevalences and patterns of major cardiovascular diseases in the developing world, as well as potential opportunities provided by early disease detection.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22858388     DOI: 10.1016/j.jacc.2012.03.074

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  112 in total

Review 1.  Stem cells: An eventual treatment option for heart diseases.

Authors:  Joseph C Bilgimol; Subbareddy Ragupathi; Lakshmanan Vengadassalapathy; Nathan S Senthil; Kalimuthu Selvakumar; M Ganesan; Sadananda Rao Manjunath
Journal:  World J Stem Cells       Date:  2015-09-26       Impact factor: 5.326

2.  Smoking and projected cardiovascular risk in an HIV-positive Asian regional cohort.

Authors:  T C Do; D Boettiger; M Law; S Pujari; F Zhang; R Chaiwarith; S Kiertiburanakul; M P Lee; R Ditangco; W W Wong; K V Nguyen; T P Merati; T T Pham; A Kamarulzaman; S Oka; E Yunihastuti; N Kumarasamy; P Kantipong; J Y Choi; O T Ng; N Durier; K Ruxrungtham
Journal:  HIV Med       Date:  2016-08       Impact factor: 3.180

Review 3.  Cholesterol-lowering drugs: science and marketing.

Authors:  Livio Garattini; Anna Padula
Journal:  J R Soc Med       Date:  2017-01-13       Impact factor: 5.344

4.  High-Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure: MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Stephen L Seliger; Susie N Hong; Robert H Christenson; Richard Kronmal; Lori B Daniels; Joao A C Lima; James A de Lemos; Alain Bertoni; Christopher R deFilippi
Journal:  Circulation       Date:  2017-02-03       Impact factor: 29.690

Review 5.  Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2013-10-21

6.  Association between dietary patterns and coronary heart disease: a meta-analysis of prospective cohort studies.

Authors:  Lina Hou; Fei Li; Yuanyuan Wang; Zejin Ou; Dingli Xu; Wanlong Tan; Meng Dai
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 7.  Biomimetic nanoparticle technology for cardiovascular disease detection and treatment.

Authors:  Joon Ho Park; Diana Dehaini; Jiarong Zhou; Maya Holay; Ronnie H Fang; Liangfang Zhang
Journal:  Nanoscale Horiz       Date:  2019-06-28       Impact factor: 10.989

8.  Peripheral vascular atherosclerosis in a novel PCSK9 gain-of-function mutant Ossabaw miniature pig model.

Authors:  Ahmad F Hedayat; Kyoung-Ha Park; Taek-Geun Kwon; John R Woollard; Kai Jiang; Daniel F Carlson; Amir Lerman; Lilach O Lerman
Journal:  Transl Res       Date:  2017-11-03       Impact factor: 7.012

9.  Exendin-4 ameliorates oxidized-LDL-induced inhibition of macrophage migration in vitro via the NF-κB pathway.

Authors:  Ge-fei Ma; Song Chen; Lei Yin; Xiang-dong Gao; Wen-bing Yao
Journal:  Acta Pharmacol Sin       Date:  2013-12-16       Impact factor: 6.150

10.  Discrimination Is Associated with Elevated Cardiovascular Disease Risk among African Immigrants in the African Immigrant Health Study.

Authors:  Ruth-Alma N Turkson-Ocran; Sarah L Szanton; Lisa A Cooper; Sherita H Golden; Rexford S Ahima; Nancy Perrin; Yvonne Commodore-Mensah
Journal:  Ethn Dis       Date:  2020-09-24       Impact factor: 1.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.